BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact

How To Avoid ACL Surgery With Stem Cell Treatment

June 3, 2022 By Cade Hildreth (CEO) 1 Comment

Feature | ACL Surgeries: How To Avoid Surgery With Stem Cell Treatment

Despite ACL surgeries being more readily available than ever before, torn knee ligaments are still one of the most dreaded injuries for athletes and other active people. The anterior cruciate ligament (ACL) is responsible for stabilizing the knee. If it tears after a sudden wrenching movement, then stability and ease of motion are destroyed. Until recently, ACL surgeries seemed to be the only way for patients to escape the pain, stiffness, and stability loss that comes with an ACL injury.

Fortunately, stem cell treatment may now represent a viable way for some patients to repair torn knee ligaments while avoiding invasive ACL surgeries.

Alternative To ACL Injuries? How Stem Cells Can Help

In this article:

  1. Why Seek an Alternative to ACL Surgery?
  2. How Stem Cell Treatment Addresses an ACL Injury
  3. The Stem Cell Procedure for an ACL Tear
  4. Will Your ACL Injury Respond Well to Stem Cell Treatment?

[Read more…]

Filed Under: Cell Therapy, Stem Cells

Interview with Dr. Nianwei Lin, Co-Founder and President of iXCells Biotechnologies

June 2, 2022 By Cade Hildreth (CEO) Leave a Comment

iXCells Biotechnologies

Founded in 2014 and headquartered in San Diego, CA, iXCells Biotechnologies is a cell biology and cell technology company specializing in pre-clinical drug discovery solutions. iXCells provides primary cells and iPSC derived cells, custom iPSC services, and functional bioassay development and execution, among other products and services.

In this interview with Nianwei Lin, Co-Founder and President of iXCells Biotechnologies, we discuss the company’s product pipeline, innovative drug discovery solutions, CRO services, and its future goals. [Read more…]

Filed Under: Interviews, iPS Cells, Stem Cell News

What Is the Future of the Stem Cell Market in 2022?

June 1, 2022 By Cade Hildreth (CEO) Leave a Comment

stem cell market

Stem cell therapy continues to rally worldwide recognition as governments fund research and expand access. This once-controversial therapy is fast becoming one of medicine’s most exciting technologies. From FDA-approved therapies to in-house, physician-initiated autologous techniques, stem cell technology continues to evolve. 2022 promises to be an exciting year for the stem cell market.

Here’s everything you need to know about the future of this revolutionary therapy. [Read more…]

Filed Under: Stem Cells

The American Academy of Stem Cell Physicians Adds Three Workshops to the June 17-19, 2022 Conference

May 16, 2022 By Cade Hildreth (CEO) Leave a Comment

AASCP Workshops 2022
The hands-on work shops will be on Intradiscal Injections, Bone Marrow Aspiration, and Musculoskeletal Ultrasound techniques.

MIAMI, May 17, 2022 – The American Academy of Stem Cell Physicians has added three new workshops to its long awaited conference this June 17-19, 2022. The hands-on workshops will be led by industry leaders from across the regenerative medicine field.  The workshops will be on Intradiscal Injections, Bone Marrow Aspiration, and Musculoskeletal UltraSound techniques. Beyond these educational workshops, the American Academy of Stem Cell is presenting a lineup of acclaimed regenerative medicine leaders in their field discussing what’s new in regenerative medicine. This conference is not to be missed! [Read more…]

Filed Under: Cell Therapy, Press Releases, Stem Cell News

PolarityTE Announces FDA RMAT Awarded to Its Designation Granted to SkinTE®

May 16, 2022 By Cade Hildreth (CEO) 1 Comment

PolarityTE RMAT

SALT LAKE CITY, May 13, 2022 –PolarityTE, Inc. (Nasdaq: PTE) today announced that the U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company’s open IND. [Read more…]

Filed Under: Cell Therapy, Press Releases

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 272
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.